Table 2.
Model 1 Standardized β (p-value) |
Model 2 Standardized β (p-value) |
|||
---|---|---|---|---|
Clinical Measures | Women | Men | Women | Men |
HOMA-IR ǂ | 0.15 (<0.0001) | 0.12 (<0.0001) | 0.11 (0.0007) | 0.06 (0.0381) |
Fasting Insulin, uU/ml ǂ | 0.14 (<0.0001) | 0.12 (<0.0001) | 0.10 (0.0020) | 0.05 (0.0385) |
Fasting Glucose, mg/dl | 0.10 (<0.0001) | 0.06 ( 0.0022) | 0.07 (0.0026) | 0.02 (0.2684) |
Waist Circumference, cm | 0.18 (<0.0001) | 0.18 (<0.0001) | 0.13 (0.0289) | 0.17 (0.0102) |
Systolic Blood Pressure, mmHg | 0.02 (0.2936) | 0.04 (0.0624) | −0.04 (0.1117) | −0.00 (0.8509) |
Diastolic Blood Pressure, mmHg | 0.05 (0.0406) | 0.07 (<0.0001) | 0.00 (0.6792) | 0.00 (0.1839) |
Fasting Triglycerides, mg/dl ǂ | 0.05 (0.0546) | 0.08 (<0.0001) | 0.05 (0.0528) | 0.03 (0.0574) |
HDL-C, mg/dl | −0.03 (0.1946) | −0.03 (0.0427) | 0.00 (0.9473) | 0.00 (0.8354) |
Model 1 is adjusted for height2 and intracellular resistance (RI).
Model 2 is adjusted for height2, RI, age, African-American race/ethnicity, Mexican American race/ethnicity, DXA lean massǂ, DXA fat massǂ, medication use, smoking, and alcohol.
indicates that variable is log-transformed.
Bold values indicate statistical significance, p < 0.05.
Abbreviations: HOMA-IR, homeostasis model assessment of insulin resistance; HDL-C, High density lipoprotein cholesterol; DXA, dual-x-ray-absorptiometry.